KalVista Pharmaceuticals : Impact of Oral Sebetralstat on Anxiety Associated with Hereditary Angioedema Attacks in the Phase 3 KONFIDENT Trial

Press/Media

Period	10 Jul 2025

Media coverage

Title	KalVista Pharmaceuticals : Impact of Oral Sebetralstat on Anxiety Associated with Hereditary Angioedema Attacks in the Phase 3 KONFIDENT Trial
Media name/outlet	MarketScreener.com
Country/Territory	United States
Date	10/07/25
URL	ct.moreover.com/?a=57183561711&p=1gw&v=1&x=WeaYF-VKGXx2jtTRxOYmMQ
Persons	Paula Busse